Evaluation of KX2-391 in Elderly Subjects With Acute Myeloid Leukemia (AML)
Clinical trial NCT01397799 · COMPLETED
Trial details
- NCT number
- NCT01397799
- Sponsor
- Kinex Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2014-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.